US Health Regulators Move to Ease Restrictions on Testosterone Therapy
US Health Regulators Move to Ease Restrictions on Testosterone Therapy
In June 2026, the US Department of Health and Human Services directed the FDA to remove long-standing
warning labels from testosterone products prescribed for age-related decline, citing updated safety evidence and
aiming to give doctors clearer guidance.
